Luis Enrique Fernandez Selected Research

montanide ISA 51

9/2010	Immunogenicity and safety of a NeuGcGM3 based cancer vaccine: Results from a controlled study in metastatic breast cancer patients.
11/2004	Active specific immunotherapy of melanoma with a GM3 ganglioside-based vaccine: a report on safety and immunogenicity.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Luis Enrique Fernandez Research Topics

Disease

3	Neoplasms (Cancer) 04/2015 - 06/2004
2	Melanoma (Melanoma, Malignant) 07/2012 - 11/2004
1	Autoimmune Diseases (Autoimmune Disease) 04/2015
1	Experimental Melanoma 07/2012
1	Neoplasm Metastasis (Metastasis) 09/2010
1	Injection Site Reaction 09/2010
1	Breast Neoplasms (Breast Cancer) 09/2010
1	Fever (Fevers) 09/2010
1	Arthralgia (Joint Pain) 09/2010
1	Chills 09/2010

Drug/Important Bio-Agent (IBA)

3	VaccinesIBA 07/2012 - 11/2004
2	GangliosidesIBA 07/2012 - 09/2010
2	Cancer VaccinesIBA 07/2012 - 09/2010
2	montanide ISA 51IBA 09/2010 - 11/2004
1	SelectinsIBA 04/2015
1	LectinsIBA 04/2015
1	Sialic Acid Binding Immunoglobulin-like LectinsIBA 04/2015
1	C-Type Lectins (C-Type Lectin)IBA 04/2015
1	Polysaccharides (Glycans)IBA 04/2015
1	Galectins (Galectin)IBA 04/2015
1	CytidineIBA 07/2012
1	N-glycolylneuraminic acidIBA 07/2012
1	Neoplasm Antigens (Tumor Antigens)IBA 07/2012
1	CMPacetylneuraminate monooxygenase (CMP-N-acetylneuraminate monooxygenase)IBA 07/2012
1	EnzymesIBA 07/2012
1	Messenger RNA (mRNA)IBA 07/2012
1	Biological ProductsIBA 09/2010
1	G(M3) GangliosideIBA 11/2004
1	ErbB Receptors (EGF Receptor)IBA 06/2004

Therapy/Procedure

1	Transplantation 04/2015
1	Immunotherapy 11/2004
1	Therapeutics 06/2004